
Rockville, MD, United States, October 22, 2024 — On Demand Pharmaceuticals (ODP), a pioneering leader in agile distributed medicine manufacturing, is thrilled to announce the appointment of Jarrod Borkat, MBA, as Chief Strategy and Commercial Officer, effective October 21, 2024. Jarrod brings more than two decades of experience in strategic leadership and commercialization, including senior roles at AstraZeneca and Boehringer Ingelheim, where he successfully drove innovation and growth in the pharmaceutical industry.
Jarrod joins ODP at a critical juncture as the company prepares to commercialize its groundbreaking platform for on-demand medicine manufacturing. This innovative technology enables healthcare providers to produce patient-ready generic sterile injectables at the point of care, addressing persistent challenges in drug shortages and supply chain vulnerabilities.